Primecap Management Co. CA Trims Stake in Health Catalyst

Institutional investor reduces holding in healthcare data analytics firm

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Primecap Management Co. CA, an institutional investor, reduced its stake in Health Catalyst, Inc. (NASDAQ:HCAT) by 31.1% during the third quarter. The firm now owns 1,369,067 shares, or about 1.95% of the healthcare data and analytics company's stock.

Why it matters

This transaction highlights the volatility in Health Catalyst's stock price and ownership structure. As a public company, Health Catalyst's shares are subject to trading by institutional investors like Primecap Management, whose investment decisions can significantly impact the stock's performance.

The details

According to a regulatory filing, Primecap Management sold 617,620 shares of Health Catalyst during the third quarter. The firm now owns 1,369,067 shares, valued at $3.9 million as of the most recent SEC disclosure. Health Catalyst's stock has traded between $1.61 and $5.06 over the past 52 weeks.

  • Primecap Management reduced its stake in Health Catalyst during the third quarter of 2026.

The players

Primecap Management Co. CA

An institutional investment management firm that owns a significant stake in Health Catalyst.

Health Catalyst, Inc.

A healthcare data and analytics technology company based in Salt Lake City, Utah.

Got photos? Submit your photos here. ›

The takeaway

This transaction underscores the volatility in Health Catalyst's stock and the shifting investment landscape for healthcare technology companies. As a public firm, Health Catalyst's performance and ownership structure will continue to be closely watched by investors and industry analysts.